Liver cirrhosis trials in China

In China 75 Also abroad 358

75 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
Where
Changsha
Age
18 years to 60 years
People
20
Run by
Sclnow Biotechnology Co., Ltd.
See details and how to joinNCT03826433
No phaseEnrolling by invitation
Pantoprazole After Prophylactic Endoscopic Variceal Treatment
Where
Shenyang
Age
18 years and over
People
208
Run by
General Hospital of Shenyang Military Region
See details and how to joinNCT07248722
No phaseTaking people
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
Where
Yangzhou
Age
18 years and over
People
15
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07462091
No phaseTaking people
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
Where
Yangzhou
Age
18 years and over
People
20
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07461532
No phaseTaking people
Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
Where
Yangzhou
Age
18 years and over
People
20
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07461545
Phase 1/2Enrolling by invitation
HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial
Where
Shanghai
Age
18 years and over
People
39
Run by
Shanghai Huicun Medical Technology Co., Ltd.
See details and how to joinNCT07488546
Phase 1/2Taking people
EUS Guided Portal-systemic Pressure Gradient Measurement
Where
Hong Kong
Age
18 years to 75 years
People
30
Run by
Chinese University of Hong Kong
See details and how to joinNCT04633356
No phaseTaking people
EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis.
Where
Hong Kong
Age
18 years to 75 years
People
160
Run by
Chinese University of Hong Kong
See details and how to joinNCT05597488
No phaseTaking people
Indicators Affecting PVT Recanalization
Where
Shanghai
Age
18 years to 80 years
People
1,500
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07473375
No phaseNot yet taking people in China
Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis.
Where
Guangzhou
Age
18 years to 80 years
People
200
Run by
Zhujiang Hospital
See details and how to joinNCT07455175
No phaseNot yet taking people in China
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
Where
Beijing, Hengshui, Qingdao, Qinhuangdao, Shenzhen, Wuxi
Age
18 years and over
People
2,522
Run by
Peking University First Hospital
See details and how to joinNCT07422701
Phase 1/2Taking people
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
Where
Wuhan
Age
18 years to 75 years
People
76
Run by
Beijing Tuohua Weiye Biotechnology Co., Ltd.
See details and how to joinNCT07413549
No phaseTaking people
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
Where
Shenyang
Age
18 years to 75 years
People
150
Run by
Shengjing Hospital
See details and how to joinNCT05475015
No phaseTaking people
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
Where
Shenyang
Age
18 years to 75 years
People
100
Run by
Shengjing Hospital
See details and how to joinNCT06205992
No phaseTaking people
Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
Where
Hangzhou, Shenzhen
Age
18 years to 80 years
People
450
Run by
Zhejiang University
See details and how to joinNCT07252102
No phaseTaking people
Underdilated-stent Technique Improves Post-TIPS Encephalopathy
Where
Chongqing, Qianjiang
Age
18 years to 75 years
People
72
Run by
The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07349654
Phase 2Not yet taking people in China
TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension
Where
Fuzhou, Jinan, Nanning, Qingdao, Taihe, Wuhan
Age
18 years to 75 years
People
78
Run by
Tongji Hospital
See details and how to joinNCT07350070
Phase 4Enrolling by invitation
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
Where
Xi’an
Age
18 years to 75 years
People
350
Run by
Xijing Hospital
See details and how to joinNCT07352228
No phaseTaking people
Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension
Where
Changsha
Age
18 years to 75 years
People
166
Run by
C. R. Bard
See details and how to joinNCT06669806
No phaseTaking people
TIPS With or Without BCAA
Where
Wuhan
Age
18 years to 80 years
People
164
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07281846
No phaseTaking people
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
Where
Jinan
Age
18 years and over
People
100
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07275554
No phaseTaking people
Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis
Where
Hangzhou
Age
18 years to 75 years
People
10
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07271576
No phaseTaking people
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
Where
Changsha, Fuzhou, Huanggang, Jingzhou, Nanchang, Nanjing, Shenyang, Taiyuan, Wuhan, Xiangyang, Yichang, Zhengzhou
Age
18 years to 80 years
People
250
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07172035
No phaseTaking people
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Where
Yangzhou
Age
18 years and over
People
30
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07205471
No phaseNot yet taking people in China
A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis
Where
Xiamen
Age
18 years to 60 years
People
30
Run by
Xiamen Humanity Hospital
See details and how to joinNCT07183293